From Surf Wiki (app.surf) — the open knowledge base
Dacemazine
Chemical compound
Chemical compound
Dacemazine (INN, also known as Ahistan and Histantine) is a phenothiazine derivative which acts as a histamine antagonist at the H1 subtype. First described in 1951, it was never marketed as a drug on its own, although a combination of dacemazine and di-tert-butylnaphthalenesulfonate was sold as an antispasmodic and antitussive under the trade name Codopectyl. It was also assessed as a possible anticancer drug.
Synthesis
Amide formation between phenothiazine (1) and chloroacetyl chloride (2) gives 10-(chloroacetyl)-phenothiazine (3). The subsequent displacement of the remaining halogen with dimethylamine (4) completes the synthesis of dacemazine (5).
References
References
- (1996). "Dictionary of Pharmacological Agents". Chapman & Hall/CRC.
- (August 1952). "[The anticarcinogenic effect of dimethylaminoacetyl-phentiazide (ahistan)]". Kiserletes Orvostudomany.
- (1951). "10-Aminoacylphenothiazines. I. Aminoacetyl and Aminopropionyl Derivatives". Acta Chemica Scandinavica.
- (1959). "Syntheses of phenothiazine drugs". Revistade Chimie.
- (1957). "Phenothiazine derivatives. II. Synthesis of 10-(alkylaminoacetyl)phenothiazines". Shionogi Kenkyusho Nempo.
- "N-(Hydroxyalkylaminoalkanoyl)phenothiazines".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Dacemazine — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report